Vascular Malformations Clinical Trial
Official title:
Development and Validation of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations Aged 11 to 15 Years-old.
The low-flow malformations include venous and lymphatic malformations. The malformation often
affects the skin and can extend deep to the muscles and bone, as well as to deep organs.
Children with low-flow vascular malformation and their family have difficulty living with
their illness and have an impact on their life quality.
In this context, the aim of the study is to develope life quality test for the children
between 11 to 15 years old.
The low-flow vascular malformations include venous and lymphatic malformations. These
malformations are made of dilated dysplastic vessels in which the circulation is lowed down,
which can lead to phenomena of thrombosis, hemorrhage, with sometimes a repercussion on the
general coagulation. The malformation often affects the skin and can extend deep to the
muscles and bone, as well as to deep organs. It presents by swelling sometimes voluminous and
often painful. Children with low-flow malformations and their families have difficulty living
with their illness and have an impact on their quality of life (QOL).
These difficulties seem relative to :
- the lack of knowledge of the disease by doctors and the general public - medical
difficulties directly related to the disease and its evolution: pain, deformation,
biological anomaly, chronicity, lack of effective treatment
- psychological difficulties related to the visible and unesthetic appearance of the
lesions
- excluding certain social activities The difficulties experienced by patients with
slow-flow malformations and their family, as well as the impact on their QOL, have never
been studied. Although QOL appears to be the best reflection of the severity of a
chronic condition, there is no QOL questionnaire that is appropriate for the slow-flow
malformations of the child or adult.
The aim of the study is to develope a specific life quality test for children between 11 to
15 years old.
These data will be used in a second time to build and validate a scale of quality of life
specific slow-flow malformations of the child aged 11 to 15 years old. The study is build in
3 parts:
Focus group: collect the dimension of the lived experience and the perceptions of the
children with slow-flow malformations as well as their needs and their expectations
Validation of the life quality test: the data obtained during focus group will be used to
develop the scale of life quality specific to the child aged 11 to 15 years suffering to
low-flow malformations. In a second time to validate the scale, this life quality test will
be send to patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02561182 -
Bone Health in Patients With Overgrowth
|
||
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Active, not recruiting |
NCT03987152 -
Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
|
Phase 3 | |
Recruiting |
NCT05113420 -
The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
|
||
Recruiting |
NCT06189092 -
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
|
||
Completed |
NCT04637997 -
Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations
|
N/A | |
Recruiting |
NCT02883023 -
Electrosclerotherapy for Capillary Malformations
|
Phase 2 | |
Recruiting |
NCT06160739 -
Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations
|
||
Completed |
NCT02991352 -
Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study
|
N/A | |
Recruiting |
NCT03972592 -
Topical Sirolimus in Cutaneous Lymphatic Malformations
|
Phase 2 | |
Active, not recruiting |
NCT05418816 -
SelfWrap-Assisted Arteriovenous Fistulas
|
N/A | |
Recruiting |
NCT04104464 -
Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
|
||
Recruiting |
NCT02638389 -
Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
|
Phase 3 | |
Recruiting |
NCT05563831 -
National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
|
||
Completed |
NCT00577213 -
Diagnosis of Hemangiomas and Vascular Malformations
|
N/A | |
Recruiting |
NCT05494710 -
Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study
|
N/A | |
Enrolling by invitation |
NCT06399367 -
Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)
|
||
Not yet recruiting |
NCT05983159 -
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
|
Phase 2 | |
Completed |
NCT01576601 -
The Management of Postoperative Craniotomy Pain in Pediatric Patients
|
N/A | |
Completed |
NCT04836884 -
Vascular Anomaly Pathology and Genomics Biopsy Study
|
N/A |